Clinical trials of newer regimens for treating ovarian cancer: the rationale for Gynecologic Oncology Group Protocol GOG 182-ICON5.

Gynecologic oncology

Volumn 90, Issue 2 Pt 2, 2003, Pages

  Copeland, Larry J ^a   Bookman, Michael ^a   Trimble, Edward ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; DEOXYCYTIDINE; DOXORUBICIN; DRUG DERIVATIVE; GEMCITABINE; LIPOSOME; PACLITAXEL; TOPOTECAN;

ARTICLE; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MULTICENTER STUDY; OVARY TUMOR; PATHOLOGY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; DEOXYCYTIDINE; DOXORUBICIN; FEMALE; HUMANS; LIPOSOMES; NEOPLASM STAGING; OVARIAN NEOPLASMS; PACLITAXEL; TOPOTECAN;

MLCS; MLOWN;

EID: 17344385880     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-8258(03)00337-8     Document Type: Article

References (0)